HEMATOLOGINIO VĖŽIO GYDYMO BŪDAI, NAUDOJANT PNP INHIBITORIUS, TOKIUS KAIP FORODEZINAS DERINYJE SU ANTI-CD20 AGENTAIS

• 收藏
• 分享

专利权人:

BioCryst Pharmaceuticals; Inc.

发明人:

Bantia, Shanta,Breitfeld, Philip,Babu, Yarlagadda Sudhakara

申请号：

LT12177257

公开号：

LT2564846T

申请日:

2008.12.10

申请国别(地区):

LT

年份:

2018

代理人:

摘要：

The present application relates to treatment of hematologic cancers, which treatments can include, e.g ., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/